This may reflect the relatively small difference in B cell expression of CD20 and FcγRIIb between these RA and SLE study patients (data not shown), in contrast to that reported for patients with B cell malignancies 20, 32. This evidence concerns the gene FCGR2B and rheumatoid arthritis.